Versant Capital Management »

Miragen Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.9k 134 21.58
2025-06-30 $1.9k 134 13.98
2025-03-31 $4.2k 313 13.48
2024-12-31 $1.6k 82 19.17

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Miragen Therapeutics

FMR
BlackRock
Deep Track Capital
Kynam Capital Management
Vanguard Group
VR Adviser
Fairmount Funds Management
Commodore Capital
Tang Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Maverick Capital
Eversept Partners
Alliancebernstein

View all funds holding Miragen Therapeutics